Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preserving predictive information under biologically plausible compression.

PNAS nexus·2026
Same author

The Extreme Diversity Of Retinal Amacrine Cells Has Deep Evolutionary Roots.

bioRxiv : the preprint server for biology·2026
Same author

Repeatability and reliability of retinal arterial hemodynamics measurement using Doppler holography.

Journal of biomedical optics·2026
Same author

Differentiation of macular atrophy secondary to neovascular age-related macular degeneration vs. de novo geographic atrophy: a multimodal analysis.

Eye (London, England)·2026
Same author

Interindividual variability in immune response to AAV ocular gene delivery across species impedes immunomonitoring.

JCI insight·2026
Same author

Neoplasms Associated with the Onset of Age-Related Macular Degeneration: A Case-Control Study Using the All of Us Cohort.

Research square·2026

Related Experiment Video

Updated: Dec 14, 2025

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.7K

Towards optogenetic vision restoration with high resolution.

Ulisse Ferrari1, Stéphane Deny1, Abhishek Sengupta1

  • 1Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, France.

Plos Computational Biology
|July 16, 2020
PubMed
Summary

Optogenetic therapy can restore vision by making retinal ganglion cells light-sensitive. This study shows these cells have small receptive fields, enabling high-resolution vision restoration, potentially exceeding legal blindness limits.

More Related Videos

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

8.0K
Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina
09:03

Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina

Published on: February 13, 2021

4.9K

Related Experiment Videos

Last Updated: Dec 14, 2025

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.7K
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

8.0K
Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina
09:03

Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina

Published on: February 13, 2021

4.9K

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Biomedical Engineering

Background:

  • Inherited retinal degenerations often spare retinal ganglion cells.
  • Optogenetic proteins can be expressed in ganglion cells to restore light sensitivity.
  • Spatial resolution of optogenetically reactivated retinas is not well understood, especially in primates.

Purpose of the Study:

  • To measure the spatial resolution of optogenetically reactivated retinas in mice and macaques.
  • To determine if optogenetically activated ganglion cells respond to stimulation of their axons, impacting spatial resolution.
  • To model the potential visual acuity achievable with optogenetic therapy.

Main Methods:

  • In vivo optogenetic therapy was administered to mouse and macaque retinas.
  • Responses to random checkerboard patterns were recorded.
  • A computational model was developed based on measured receptive field sizes.

Main Results:

  • Optogenetically activated ganglion cells demonstrated sensitivity to small regions of visual space.
  • The model accurately predicted cellular responses to complex stimuli.
  • Simulations predicted visual acuity above the legal blindness threshold.

Conclusions:

  • Optogenetic therapy can achieve high-resolution vision restoration.
  • The spatial resolution is determined by small receptive fields of individual ganglion cells.
  • The developed model can predict acuity variations based on therapeutic strategy adjustments.